Viral neuroinvasion and neurotropism without neuronal damage in the hACE2 mouse model of COVID-19

Frauke Seehusen; Jordan J. Clark; Parul Sharma; Eleanor Bentley; Adam Kirby; Krishanthi Subramaniam; Sabina Wunderlin Giuliani; Grant Hughes; Edward I Patterson; Benedict D Michael; Andrew Owen; Julian Alexander Hiscox; James P Stewart; Anja Kipar.
Preprint en Inglés | PREPRINT-BIORXIV | ID: ppbiorxiv-440173

Documentos relacionados

  1. Neuroinvasion and Neurotropism by SARS-CoV-2 Variants in the K18-hACE2 Mouse.
  2. Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19.
  3. Non-cell-autonomous disruption of nuclear architecture as a potential cause of COVID-19-induced anosmia.
  4. PHEV infection: A promising model of betacoronavirus-associated neurological and olfactory dysfunction.
  5. Mechanisms of SARS-CoV-2 entry into cells.
  6. Pathophysiology of SARS-CoV-2 Infection of Nasal Respiratory and Olfactory Epithelia and Its Clinical Impact.
  7. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
  8. Covalently Engineered Protein Minibinders with Enhanced Neutralization Efficacy against Escaping SARS-CoV-2 Variants.
  9. K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research.
  10. [Omicron Variant of SARS-CoV-2 and Its Potential Impact on Dental Practice].